rs74389479
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001388419.1(KALRN):c.4171C>A(p.His1391Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001388419.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001388419.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KALRN | MANE Select | c.4171C>A | p.His1391Asn | missense | Exon 27 of 60 | NP_001375348.1 | O60229-7 | ||
| KALRN | c.4165C>A | p.His1389Asn | missense | Exon 27 of 60 | NP_001019831.2 | O60229-1 | |||
| KALRN | c.4165C>A | p.His1389Asn | missense | Exon 27 of 49 | NP_001309917.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KALRN | MANE Select | c.4171C>A | p.His1391Asn | missense | Exon 27 of 60 | ENSP00000508359.1 | O60229-7 | ||
| KALRN | TSL:1 | c.4165C>A | p.His1389Asn | missense | Exon 27 of 34 | ENSP00000240874.3 | O60229-2 | ||
| KALRN | TSL:1 | c.4138C>A | p.His1380Asn | missense | Exon 27 of 34 | ENSP00000418611.1 | C9IZQ6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.